Filing Flows

Filing Flows › Pfizer (PFE) › Next earnings date

Pfizer (PFE) earnings: beat the estimate

Pfizer (PFE) reported on Nov 3, 2026 and beat the EPS estimate: $0.87 against $0.74 (+18.3%). Revenue was $16.6B for Q3 2026, -0.4% year over year. The stock moved +0.4% on the report. It beat the EPS estimate in 100% of the quarters on record.

Last result+18.3% vs estimate
Beat rate100%

The last report

Pfizer reported revenue of $16.6B for the third quarter 2026 (-0.4% Y/Y), net earnings $3.3B. How it makes money → · Every quarter →

Pfizer: EPS against the estimate, last 5 reportsPfizer: EPS against the estimate, last 5 reportsEstimateReported$0.63$0.87Nov 25$0.57$0.66Feb 26$0.72$0.75May 26$0.68$0.77Aug 26$0.74$0.87Nov 26
Latest (Nov 26): Estimate $0.74, Reported $0.87.
PFE: the stock's move on each reportPFE: the stock's move on each reportNov 3, 2026+0.4%Aug 4, 2026+3.1%May 5, 2026+0.9%Feb 3, 2026+0.5%Nov 4, 2025-0.2%

Pfizer's latest quarter

Pfizer, Q3 2026: revenue $16.6B (-0.4% year over year), operating margin 20.4%, net earnings $3.3B, operating cash flow $5.4B. The chart follows the revenue to costs, profit and cash.

Questions

Did Pfizer beat earnings?

Pfizer (PFE) reported on Nov 3, 2026 and beat the EPS estimate: $0.87 against $0.74 (+18.3%).

When does PFE report earnings?

The next date is not set yet.

Does Pfizer usually beat earnings?

It beat the consensus EPS estimate in 100% of the quarters on record.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.